![](https://www.rickilewis.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0pkQVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0ee9e62432db0b54f4681421bb50ea445b9c3862/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJYW5CbkJqb0dSVlE2RkhKbGMybDZaVjkwYjE5c2FXMXBkRnNIYVFMZ0FXa0M0QUU9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--d00c0b801be2eac628730b2b4ffb891cbdd69dfe/NHGRI-85335_2.jpg)
(NHGRI)
In recent weeks, there’s been talk of three types of genetic testing transitioning from targeted populations to the general public: carrier screens for recessive diseases, tests for BRCA cancers, and non-invasive prenatal testing (NIPT) to spot extra chromosomes in fetuses from DNA in the maternal bloodstream.
Are these efforts the leading edge of a new eugenics movement? It might appear that way, but I think not.
When I began providing genetic counseling 30 years ago at CareNet, a large ob/gyn practice in Schenectady, NY, Read More
Are these efforts the leading edge of a new eugenics movement? It might appear that way, but I think not.
When I began providing genetic counseling 30 years ago at CareNet, a large ob/gyn practice in Schenectady, NY, Read More